In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests

The skin often provides initial clues of hypercoagulability with features such as livedo reticularis, livedo racemosa, retiform purpura, necrosis, and ulcerations. Because these cutaneous manifestations are nonspecific, laboratory testing is often needed to evaluate for underlying causes of hypercoa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American Academy of Dermatology 2021-08, Vol.85 (2), p.301-310
Hauptverfasser: Nusbaum, Kelsey B., Korman, Abraham M., Tyler, Kelly H., Kaffenberger, Jessica A., Trinidad, John C., Dean, Steven, Cataland, Spero, Kaffenberger, Benjamin H.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 310
container_issue 2
container_start_page 301
container_title Journal of the American Academy of Dermatology
container_volume 85
creator Nusbaum, Kelsey B.
Korman, Abraham M.
Tyler, Kelly H.
Kaffenberger, Jessica A.
Trinidad, John C.
Dean, Steven
Cataland, Spero
Kaffenberger, Benjamin H.
description The skin often provides initial clues of hypercoagulability with features such as livedo reticularis, livedo racemosa, retiform purpura, necrosis, and ulcerations. Because these cutaneous manifestations are nonspecific, laboratory testing is often needed to evaluate for underlying causes of hypercoagulability. Importantly, these disorders are reported to be the most common mimicker, resulting in an erroneous diagnosis of pyoderma gangrenosum. Understanding inherent properties of, and indications for, available tests is necessary for appropriate ordering and interpretation of results. Additionally, ordering of these tests in an indiscriminate manner may lead to inaccurate results, complicating the interpretation and approach to management. This second article in this continuing medical education series summarizes information on methodology, test characteristics, and limitations of several in vitro laboratory tests used for the work up of hypercoagulability and vasculopathic disease as it pertains to dermatologic disease.
doi_str_mv 10.1016/j.jaad.2021.03.108
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2513241152</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962221006812</els_id><sourcerecordid>2513241152</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-31b18ca400544ca8e79fe63a8c8f01e4d462b4165a8bc05b230b1cce7b0bb2353</originalsourceid><addsrcrecordid>eNp9kEtLAzEUhYMoWh9_wIVk6WbGm2QeGXEj4qMg6ELXIcncqSnTpiap0H9vStWlq8s9nHMu9yPknEHJgDVX83KudV9y4KwEkTW5RyYMurZoWtnukwmwDoqu4fyIHMc4B4CuEu0hORJC1rzj3YS8T5f0y6Xgae_0bOljcjbSwQeaPpAusHdWj7THsNDJj37mYirpqw6JTqfX9GmzwmC9nq1Hbdzo0oYmjCmekoNBjxHPfuYJeX-4f7t7Kp5fHqd3t8-FFXWTCsEMk1ZXAHVVWS2x7QZshJZWDsCw6quGm4o1tZbGQm24AMOsxdaAyUstTsjlrncV_Oc6X1YLFy2Oo16iX0fFayZ4xVjNs5XvrDb4GAMOahXcQoeNYqC2ONVcbXGqLU4FImsyhy5--tcms_iL_PLLhpudAfOXXw6Ditbh0mZuAW1SvXf_9X8DYMiGSA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2513241152</pqid></control><display><type>article</type><title>In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests</title><source>Access via ScienceDirect (Elsevier)</source><creator>Nusbaum, Kelsey B. ; Korman, Abraham M. ; Tyler, Kelly H. ; Kaffenberger, Jessica A. ; Trinidad, John C. ; Dean, Steven ; Cataland, Spero ; Kaffenberger, Benjamin H.</creator><creatorcontrib>Nusbaum, Kelsey B. ; Korman, Abraham M. ; Tyler, Kelly H. ; Kaffenberger, Jessica A. ; Trinidad, John C. ; Dean, Steven ; Cataland, Spero ; Kaffenberger, Benjamin H.</creatorcontrib><description>The skin often provides initial clues of hypercoagulability with features such as livedo reticularis, livedo racemosa, retiform purpura, necrosis, and ulcerations. Because these cutaneous manifestations are nonspecific, laboratory testing is often needed to evaluate for underlying causes of hypercoagulability. Importantly, these disorders are reported to be the most common mimicker, resulting in an erroneous diagnosis of pyoderma gangrenosum. Understanding inherent properties of, and indications for, available tests is necessary for appropriate ordering and interpretation of results. Additionally, ordering of these tests in an indiscriminate manner may lead to inaccurate results, complicating the interpretation and approach to management. This second article in this continuing medical education series summarizes information on methodology, test characteristics, and limitations of several in vitro laboratory tests used for the work up of hypercoagulability and vasculopathic disease as it pertains to dermatologic disease.</description><identifier>ISSN: 0190-9622</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2021.03.108</identifier><identifier>PMID: 33852929</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>antiphospholipid antibodies ; cryofibrinogenemia ; cryoglobulinemia ; D-dimer ; diagnostic testing ; factor deficiency ; genetic thrombophilia ; hereditary thrombophilia ; hypercoagulability ; medical dermatology ; monoclonal gammopathy ; multiple myeloma ; pyoderma gangrenosum ; retiform purpura ; thrombogenic vasculopathy ; thrombotic vasculopathy ; ulcer</subject><ispartof>Journal of the American Academy of Dermatology, 2021-08, Vol.85 (2), p.301-310</ispartof><rights>2021 American Academy of Dermatology, Inc.</rights><rights>Copyright © 2021 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-31b18ca400544ca8e79fe63a8c8f01e4d462b4165a8bc05b230b1cce7b0bb2353</citedby><cites>FETCH-LOGICAL-c356t-31b18ca400544ca8e79fe63a8c8f01e4d462b4165a8bc05b230b1cce7b0bb2353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaad.2021.03.108$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33852929$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nusbaum, Kelsey B.</creatorcontrib><creatorcontrib>Korman, Abraham M.</creatorcontrib><creatorcontrib>Tyler, Kelly H.</creatorcontrib><creatorcontrib>Kaffenberger, Jessica A.</creatorcontrib><creatorcontrib>Trinidad, John C.</creatorcontrib><creatorcontrib>Dean, Steven</creatorcontrib><creatorcontrib>Cataland, Spero</creatorcontrib><creatorcontrib>Kaffenberger, Benjamin H.</creatorcontrib><title>In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><description>The skin often provides initial clues of hypercoagulability with features such as livedo reticularis, livedo racemosa, retiform purpura, necrosis, and ulcerations. Because these cutaneous manifestations are nonspecific, laboratory testing is often needed to evaluate for underlying causes of hypercoagulability. Importantly, these disorders are reported to be the most common mimicker, resulting in an erroneous diagnosis of pyoderma gangrenosum. Understanding inherent properties of, and indications for, available tests is necessary for appropriate ordering and interpretation of results. Additionally, ordering of these tests in an indiscriminate manner may lead to inaccurate results, complicating the interpretation and approach to management. This second article in this continuing medical education series summarizes information on methodology, test characteristics, and limitations of several in vitro laboratory tests used for the work up of hypercoagulability and vasculopathic disease as it pertains to dermatologic disease.</description><subject>antiphospholipid antibodies</subject><subject>cryofibrinogenemia</subject><subject>cryoglobulinemia</subject><subject>D-dimer</subject><subject>diagnostic testing</subject><subject>factor deficiency</subject><subject>genetic thrombophilia</subject><subject>hereditary thrombophilia</subject><subject>hypercoagulability</subject><subject>medical dermatology</subject><subject>monoclonal gammopathy</subject><subject>multiple myeloma</subject><subject>pyoderma gangrenosum</subject><subject>retiform purpura</subject><subject>thrombogenic vasculopathy</subject><subject>thrombotic vasculopathy</subject><subject>ulcer</subject><issn>0190-9622</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLAzEUhYMoWh9_wIVk6WbGm2QeGXEj4qMg6ELXIcncqSnTpiap0H9vStWlq8s9nHMu9yPknEHJgDVX83KudV9y4KwEkTW5RyYMurZoWtnukwmwDoqu4fyIHMc4B4CuEu0hORJC1rzj3YS8T5f0y6Xgae_0bOljcjbSwQeaPpAusHdWj7THsNDJj37mYirpqw6JTqfX9GmzwmC9nq1Hbdzo0oYmjCmekoNBjxHPfuYJeX-4f7t7Kp5fHqd3t8-FFXWTCsEMk1ZXAHVVWS2x7QZshJZWDsCw6quGm4o1tZbGQm24AMOsxdaAyUstTsjlrncV_Oc6X1YLFy2Oo16iX0fFayZ4xVjNs5XvrDb4GAMOahXcQoeNYqC2ONVcbXGqLU4FImsyhy5--tcms_iL_PLLhpudAfOXXw6Ditbh0mZuAW1SvXf_9X8DYMiGSA</recordid><startdate>20210801</startdate><enddate>20210801</enddate><creator>Nusbaum, Kelsey B.</creator><creator>Korman, Abraham M.</creator><creator>Tyler, Kelly H.</creator><creator>Kaffenberger, Jessica A.</creator><creator>Trinidad, John C.</creator><creator>Dean, Steven</creator><creator>Cataland, Spero</creator><creator>Kaffenberger, Benjamin H.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210801</creationdate><title>In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests</title><author>Nusbaum, Kelsey B. ; Korman, Abraham M. ; Tyler, Kelly H. ; Kaffenberger, Jessica A. ; Trinidad, John C. ; Dean, Steven ; Cataland, Spero ; Kaffenberger, Benjamin H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-31b18ca400544ca8e79fe63a8c8f01e4d462b4165a8bc05b230b1cce7b0bb2353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>antiphospholipid antibodies</topic><topic>cryofibrinogenemia</topic><topic>cryoglobulinemia</topic><topic>D-dimer</topic><topic>diagnostic testing</topic><topic>factor deficiency</topic><topic>genetic thrombophilia</topic><topic>hereditary thrombophilia</topic><topic>hypercoagulability</topic><topic>medical dermatology</topic><topic>monoclonal gammopathy</topic><topic>multiple myeloma</topic><topic>pyoderma gangrenosum</topic><topic>retiform purpura</topic><topic>thrombogenic vasculopathy</topic><topic>thrombotic vasculopathy</topic><topic>ulcer</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nusbaum, Kelsey B.</creatorcontrib><creatorcontrib>Korman, Abraham M.</creatorcontrib><creatorcontrib>Tyler, Kelly H.</creatorcontrib><creatorcontrib>Kaffenberger, Jessica A.</creatorcontrib><creatorcontrib>Trinidad, John C.</creatorcontrib><creatorcontrib>Dean, Steven</creatorcontrib><creatorcontrib>Cataland, Spero</creatorcontrib><creatorcontrib>Kaffenberger, Benjamin H.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nusbaum, Kelsey B.</au><au>Korman, Abraham M.</au><au>Tyler, Kelly H.</au><au>Kaffenberger, Jessica A.</au><au>Trinidad, John C.</au><au>Dean, Steven</au><au>Cataland, Spero</au><au>Kaffenberger, Benjamin H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2021-08-01</date><risdate>2021</risdate><volume>85</volume><issue>2</issue><spage>301</spage><epage>310</epage><pages>301-310</pages><issn>0190-9622</issn><eissn>1097-6787</eissn><abstract>The skin often provides initial clues of hypercoagulability with features such as livedo reticularis, livedo racemosa, retiform purpura, necrosis, and ulcerations. Because these cutaneous manifestations are nonspecific, laboratory testing is often needed to evaluate for underlying causes of hypercoagulability. Importantly, these disorders are reported to be the most common mimicker, resulting in an erroneous diagnosis of pyoderma gangrenosum. Understanding inherent properties of, and indications for, available tests is necessary for appropriate ordering and interpretation of results. Additionally, ordering of these tests in an indiscriminate manner may lead to inaccurate results, complicating the interpretation and approach to management. This second article in this continuing medical education series summarizes information on methodology, test characteristics, and limitations of several in vitro laboratory tests used for the work up of hypercoagulability and vasculopathic disease as it pertains to dermatologic disease.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>33852929</pmid><doi>10.1016/j.jaad.2021.03.108</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0190-9622
ispartof Journal of the American Academy of Dermatology, 2021-08, Vol.85 (2), p.301-310
issn 0190-9622
1097-6787
language eng
recordid cdi_proquest_miscellaneous_2513241152
source Access via ScienceDirect (Elsevier)
subjects antiphospholipid antibodies
cryofibrinogenemia
cryoglobulinemia
D-dimer
diagnostic testing
factor deficiency
genetic thrombophilia
hereditary thrombophilia
hypercoagulability
medical dermatology
monoclonal gammopathy
multiple myeloma
pyoderma gangrenosum
retiform purpura
thrombogenic vasculopathy
thrombotic vasculopathy
ulcer
title In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A43%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20diagnostics%20for%20the%20medical%20dermatologist.%20Part%20II:%20Hypercoagulability%20tests&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Nusbaum,%20Kelsey%20B.&rft.date=2021-08-01&rft.volume=85&rft.issue=2&rft.spage=301&rft.epage=310&rft.pages=301-310&rft.issn=0190-9622&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2021.03.108&rft_dat=%3Cproquest_cross%3E2513241152%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2513241152&rft_id=info:pmid/33852929&rft_els_id=S0190962221006812&rfr_iscdi=true